SCHEMBL8002511

SCHEMBL8002511

Nc1cc[c]c(Cl)c1[N+](=O)[O-]

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
USP2 O75604 1/20 0.38
KEAP1 Q14145 1/20 0.38
NFE2L2 Q16236 1/20 0.38
TDP1 Q9NUW8 6/20 0.37
MAPT P10636 2/20 0.37
POLB P06746 1/20 0.37
ALDH1A1 P00352 8/20 0.37
LMNA P02545 2/20 0.37
HTT P42858 2/20 0.37
NPC1 O15118 1/20 0.37
TP53 P04637 1/20 0.37
HPGD P15428 1/20 0.37
XBP1 P17861 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TLR9 Q9NR96 1/20 0.37
TSHR P16473 3/20 0.36
CYP3A4 P08684 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9528410 0.80 ALDH1A1 (0.43) TDP1MAPTALDH1A1LMNAHTT
SCHEMBL11049111 0.78 TSHR (0.41) MEN1KMT2ATDP1MAPTPOLB
SCHEMBL28545972 0.77 ALDH1A1 (0.36) MEN1KMT2ATDP1MAPTPOLB
SCHEMBL6703354 0.77 TDP1 (0.41) MEN1KMT2AUSP2KEAP1NFE2L2
SCHEMBL8069993 0.74 ALDH1A1 (0.47) MEN1KMT2AUSP2KEAP1NFE2L2
SCHEMBL27670471 0.73 TDP1 (0.41) MEN1KMT2ATDP1MAPTPOLB
SCHEMBL6963561 0.73 MAPT (0.41) MEN1KMT2ATDP1MAPTPOLB
SCHEMBL27832802 0.71 MEN1 (0.53) MEN1KMT2AUSP2KEAP1NFE2L2
SCHEMBL9703411 0.68 TSHR (0.54) MEN1KMT2AUSP2KEAP1NFE2L2
SCHEMBL203912 0.68 TSHR (0.44) MEN1KMT2AUSP2KEAP1NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6093821-A MAKING 6-(PHENYL OR HETEROARYL)-1,2-DIHYDRO-N-1-PROTECTED QUINOLINE BY REACTING THE CORRESPONDING 6-HALO-DERIVATIVE WITH AN ORGANOBORATE AND ACID TREATMENT TO FORM THE 6-BORO-DERIVATIVE, COUPLING WITH PHENYL OR HETEROARYL HALIDE LIGAND PHARMACEUTICALS INCORPORATED (US) 2000-07-25 US disclosed